• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, SA VORICONAZOLE VO 32 WW S30 - 412490

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, SA VORICONAZOLE VO 32 WW S30 - 412490 Back to Search Results
Catalog Number 412490
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/07/2022
Event Type  malfunction  
Event Description
Intended use: etest is an agar-based gradient technique for quantitative antifungal susceptibility testing (afst).The system comprises a predefined concentration gradient of a specific antifungal agent which is used to determine the minimum inhibitory concentration (mic), in ¿g/ml, that inhibits the growth of the test organism under defined testing conditions.Description of the issue: this complaint has been created internally following the review of a scientific publication "evaluation of the sensititre yeastone and etest in comparison with clsi m38-a2 for antifungal susceptibility testing of three azoles, amphotericin b, caspofungin, and anidulafungin, against aspergillus fumigatus and other species, using new clinical breakpoints and epidemiological cutoff values" written in brazil by.Melhem et al.Which documents performance issues of several etest reference including etest voriconazole vo 32 ww s30 - reference 412490 ( lot not specified) when testing aspergillus sp.The publication reported thirty-three (33) major errors (me) and two (2) minor errors (mie).Moreover, a gap between the performances claimed and those highlighted in the article is observed : voriconazole (vcz) ea = 87,3% (48/55) ca = 36,4% (20/55) me n=33 mie n=2 (documented in this complaint) performance claimed : ea = 99 %.Anidulafungin (and): ea = 66,7% (14/21) ca = not applied ( documented in (b)(4)) performance claimed : ea = 96 %.Itraconazole (itc): ea = 82,8% (53/64) ca = 90,6% (58/64) vme n=5 me n=1 (documented in (b)(4)) performance claimed : ea = 94 %.Amphotericin b (amb): ea = 82,1% (69/84) ca = 95,2% (80/84) me n=4 (documented in (b)(4)) performance claimed : ea = 90 % the publication indicates that the isolates were originally recovered from 106 patients of hc-fmusp, brazil.There is no indication that the results have been used for medical decision.This discrepancy was reviewed for vigilance reporting according to 21 cfr 803 concerning medical device reporting.Biomérieux internal standard operational procedures states that a false resistant result could have a negative influence on the treatment decision.This limits the treatment options available to the clinician, leading to possible less effective or not appropriate drug.This review has determined that this event meets the criteria for reporting as a malfunction.Although this event does not allege that death or serious injury actually occurred, it has been determined that there is potential for serious injury should the situation recur while testing a patient isolate.Moreover, the reference 412489 which is equivalent of the etest voriconazole vo 32 ww s30 - reference 412490 - is sold in the united states market.A biomérieux internal investigation will be initiated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VORICONAZOLE VO 32 WW S30 - 412490
Type of Device
VORICONAZOLE VO 32 WW S30 - 412490
Manufacturer (Section D)
BIOMERIEUX, SA
3 route de port michaud
la balme 38390
FR  38390
Manufacturer (Section G)
BIOMERIEUX, SA
3 route de port michaud
la balme 38390
FR   38390
Manufacturer Contact
pauline prévitali
5 rue des aqueducs
craponne 69290
FR   69290
MDR Report Key15843773
MDR Text Key307995411
Report Number9615754-2022-00131
Device Sequence Number1
Product Code NGZ
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K082534
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/22/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number412490
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/07/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-